Bioequivalence of different prednisolone tablet formulations

Arzneimittel-Forschung/Drug Research

Volumn 51, Issue 8, 2001, Pages 638-642

  Luippold, G ^a   Benohr P ^a   Schneider, S ^a   Marto, M ^a   Muhlbauer B ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

CAS 50 24 8; Prednisolon Ferring; Prednisolone, bioequiva lence, clinical studies

Indexed keywords

PREDNISOLONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TABLET; TABLET FORMULATION;

EID: 0034889890     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300094     Document Type: Article

References (15)

1. Pharmacokinetics of intravenous and oral prednisolone
2. Dose-dependent prednisolone kinetics
3. Bioavailability of prednisolone tablets
4. The pharmacokinetics of corticosteroid agents
5. Human corticosteroid binding globulin
6. The binding of prednisolone in human serum and to recrystallized human albumin in vitro
7. Effects of diphenylhydantoin, phenobarbital, and diazepam on the metabolism of methylprednisolone and its sodium succinate
8. Dose dependent pharmacokinetics of prednisone and prednisolone in man
9. Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets
10. Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration
11. Bioequivalence. An updated reappraisal addressed to applications of interchangeable multi-source pharmaceutical products
12. Macrocortin: A polypeptide causing the anti-phospholipase effect of glucocorticoids
13. Drug bioavailability studies